Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
Holding ZVRA?
Track your performance easily

Zevra Therapeutics (ZVRA) Financial Statements

742 Followers

Zevra Therapeutics Financial Overview

Zevra Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.352; its P/E ratio is -4.33; Zevra Therapeutics is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 2.90M$ 8.47M$ 2.88M$ 2.32M$ 2.87M
Gross Profit$ 2.75M$ 8.47M$ 125.00K$ -143.00K$ 2.73M
EBIT$ -13.50M$ -4.96M$ -12.93M$ -9.80M$ -6.53M
EBITDA$ -13.44M$ -4.88M$ -12.85M$ -9.50M$ -6.13M
Net Income Common Stockholders$ -14.04M$ -5.08M$ 19.84M$ -9.02M$ -6.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 83.43M$ 87.37M$ 95.28M$ 82.85M$ 75.89M
Total Assets$ 138.98M$ 105.52M$ 106.59M$ 115.53M$ 119.55M
Total Debt$ 44.82M$ 13.79M$ 14.12M$ 14.12M$ 14.23M
Net Debt$ -38.60M$ -73.58M$ -81.16M$ -68.72M$ -61.66M
Total Liabilities$ 71.51M$ 37.02M$ 35.19M$ 29.72M$ 25.76M
Stockholders Equity$ 67.47M$ 68.50M$ 71.40M$ 85.81M$ 93.79M
Cash Flow-
Free Cash Flow$ -4.80M$ -8.83M$ -3.97M$ -4.50M$ -6.63M
Operating Cash Flow$ -4.63M$ -8.81M$ -3.94M$ -4.46M$ -6.60M
Investing Cash Flow$ -44.46M$ 34.04M$ -17.55M$ -63.00K$ 272.00K
Financing Cash Flow$ 26.26M$ 951.00K$ -3.75M$ -257.00K$ -409.00K
Currency in USD

Zevra Therapeutics Earnings and Revenue History

Zevra Therapeutics Debt to Assets

Zevra Therapeutics Cash Flow

Zevra Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis